JW Shinyak Corporation (KOSDAQ:067290)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,429.00
-29.00 (-1.99%)
Last updated: Oct 10, 2025, 11:47 AM KST
-1.99%
Market Cap77.59B
Revenue (ttm)86.95B
Net Income (ttm)14.05B
Shares Out53.22M
EPS (ttm)263.99
PE Ratio5.52
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume75,258
Average Volume63,958
Open1,458.00
Previous Close1,458.00
Day's Range1,420.00 - 1,462.00
52-Week Range1,220.00 - 2,020.00
Beta0.76
RSI36.04
Earnings DateNov 14, 2025

About JW Shinyak

JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheum... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1981
Employees 183
Stock Exchange KOSDAQ
Ticker Symbol 067290
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.